Position in AZN
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$1,300,603
-$48,183 QoQ
Shares Held
6,859
+0.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#602
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Optas, LLC holds $14,428,752 across 12 Drug Manufacturers - General names. AZN ranks #4 (9.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,980 | $4,773,731 | |
| 2 | JNJ |
Johnson & Johnson
|
9,047 | $2,297,666 | |
| 3 | ABBV |
AbbVie Inc.
|
7,513 | $1,890,569 | |
| 4 | AZN |
Astrazeneca PLC
This page
|
6,859 | $1,300,603 | |
| 5 | MRK |
Merck & Co., Inc.
|
9,402 | $1,208,156 | |
| 6 | AMGN |
Amgen Inc
|
1,817 | $657,970 | |
| 7 | NVS |
Novartis AG
|
4,098 | $642,237 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,803 | $480,470 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,300,603 | 6,859 | Shares | Other | 2026-07-21 | |
| 2026-03-31 | $1,348,786 | 6,839 | Shares | Other | 2026-04-27 | |
| No filing history on record for this holder in this stock. | ||||||